Posted CP-CTNet Newsletter - September 2022
Featured Article: CP-CTNet Cross Network Study: Lynch Syndrome. Inherited susceptibility to cancer involves defects in genes that normally function to suppress the formation of tumors. One such syndrome was recognized by... Read More
POSTED: 09/30/2022
SOURCE: CP-CTNet DMACC Website
Welcome to ULACNet Update, where we share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page As we... Read More
POSTED: 09/23/2022
SOURCE: DCP News
Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-... Read More
POSTED: 09/15/2022
SOURCE: Cancer Prevention Science Blog
Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story. This month’s blog post highlights how a cruciferous vegetable extract... Read More
POSTED: 08/24/2022
SOURCE: Cancer Prevention Science Blog
In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.... Read More
POSTED: 08/10/2022
SOURCE: Cancer Prevention Science Blog
CP-CTNet Newsletter - July 2022
Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More
POSTED: 07/22/2022
SOURCE: CP-CTNet DMACC Website
Unlike many other cancers, the incidence and death rates for uterine cancer are rising. Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for... Read More
POSTED: 06/28/2022
SOURCE: Cancer Prevention Science Blog
‘The complexities are staggering.’ U.S. plans huge trial of blood tests for multiple cancers
National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever Read More
POSTED: 06/22/2022
SOURCE: Science Magazine
Key Messages Although aspirin use has been studied for decades, there are still many gaps in our understanding its role in cancer prevention. Risk-benefit analyses should be conducted to ensure that the right patients are... Read More
POSTED: 06/15/2022
SOURCE: DCP News
In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type... Read More
POSTED: 05/06/2022
SOURCE: Cancer Prevention Science Blog
Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page The... Read More
POSTED: 04/28/2022
SOURCE: DCP News
Screening for Many Cancers with One Test: Uncertainty Abounds
One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage cancer.... Read More
POSTED: 04/21/2022
SOURCE: NCI Cancer Currents Blog
Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one... Read More
POSTED: 04/18/2022
SOURCE: Cancer Prevention Science Blog
Can Cancer Blood Tests Live Up to Promise of Saving Lives?
Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET... Read More
POSTED: 04/11/2022
SOURCE: AP News
April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous... Read More
POSTED: 04/01/2022
SOURCE: DCP News
CP-CTNet Newsletter - March 2022
Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More
POSTED: 03/31/2022
SOURCE: CP-CTNet DMACC Website
Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being... Read More
POSTED: 03/25/2022
SOURCE: ECOG-ACRIN Press Release
RESEARCH UPDATE: ON THE CLINICAL FRONT Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Colon Adenoma Patients Preclinical studies suggest calcium, vitamin D, and vitamin D... Read More
POSTED: 03/18/2022
SOURCE: DCP News
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat... Read More
POSTED: 02/09/2022
SOURCE: Cancer Prevention Science Blog
Study Identifies Potential Drug Target to Prevent Some Liver Cancers
While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C... Read More
POSTED: 02/04/2022
SOURCE: NCI Cancer Currents Blog
Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page... Read More
POSTED: 01/28/2022
SOURCE: DCP News
Even If Insured, People with Advanced Cancer Often Face Financial Problems
Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study. Read More
POSTED: 01/26/2022
SOURCE: NCI Cancer Currents Blog
Key Messages There are many screening questions that can be addressed through clinical trials. One size doesn’t fit all: There is a trend for increasingly personalized screening, where cancer screening recommendations are... Read More
POSTED: 01/25/2022
SOURCE: DCP News
A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July 16, 2021... Read More
POSTED: 01/20/2022
SOURCE: DCP News
Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people... Read More
POSTED: 01/14/2022
SOURCE: Cancer Prevention Science Blog
